Digital therapeutic Click Therapeutics has tapped AI-backed neurological disease diagnostic Altoida in to help it incorporate more sensitive measures of cognition into their DTx research.
The partnership will bring Altoida's cognition measuring capabilities into Click's clinical trials.
“Partnering with Altoida allows us to leverage their AI-driven augmented reality technology to help us better...
